The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease

被引:0
|
作者
Sollelis, E. [1 ,2 ,3 ]
Quinard, R. Minet [4 ]
Bouguen, G. [5 ]
Goutte, M. [1 ,2 ,3 ]
Goutorbe, F. [1 ,6 ]
Bouvier, D. [4 ]
Pereira, B. [7 ]
Bommelaer, G. [1 ,2 ,3 ]
Buisson, A. [1 ,2 ,3 ]
机构
[1] Univ Hosp Estaing, Gastroenterol Dept, Clermont Ferrand, France
[2] Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France
[3] USC INRA 2018, Microbes Intestine Inflammat & Susceptibil Host, Clermont Ferrand, France
[4] Univ Hosp G Montpied, Biochem Lab, Clermont Ferrand, France
[5] Univ Hosp, Rennes, France
[6] Hosp Bayonne, Gastroenterol Dept, Bayonne, France
[7] Univ Hosp, Biostat Unit, DRCI Clermont Ferrand, Clermont Ferrand, France
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P504
引用
收藏
页码:S360 / S360
页数:1
相关论文
共 50 条
  • [21] Maintenance of deep remission in Crohn's disease after switching from anti-TNF to ustekinumab
    Mantzaris, C.
    Vraka, M.
    Beka, H.
    Georgiadi, T.
    Albani, F.
    Veretanos, C.
    Mountaki, K.
    Trikola, A.
    Archavlis, E.
    Christidou, A.
    Manolakis, A.
    Viazis, N.
    Karampekos, G.
    Philippidis, G.
    Hatzievangelinou, C.
    Tsatsa, A.
    Georgiadou, A.
    Panagopoulou, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S366 - S367
  • [22] Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients
    Chen, Nai-Yu
    Chiu, Yung-Ting
    Chuang, Chiao-Hsiung
    Chang, Yu-Ching
    Cheng, Ching-Lan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 356 - 356
  • [23] Initial Adequate Trough Concentrations during Induction Therapy Correlate with Sustained TNF Suppression and Predict Remission with Adalimumab in Anti-TNF Naive Crohn's Disease Patients
    Vande Casteele, N.
    Mould, D.
    Tops, S.
    Vandenbroeck, K.
    Ballet, V.
    Ferrante, M.
    Van Assche, G.
    Gils, A.
    Vermeire, S.
    Baert, F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S44 - S45
  • [24] TRANSMURAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF THERAPY
    Pastaud, Clement
    Hordonneau, Constance
    Lambert, Celine
    Vignette, Jeanne
    Pereira, Bruno
    Buisson, Anthony
    GASTROENTEROLOGY, 2020, 158 (06) : S953 - S954
  • [25] Faecal calprotectin is capable of predicting mucosal healing in paediatric-onset Crohn's disease patients under sustained clinical remission with biologics
    Kang, B.
    Kim, J. Y.
    Lee, K.
    Choe, B. -H.
    Choe, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S443 - S443
  • [26] Anti-TNF Therapy and Radiation Exposure in Crohn's Disease
    Aggarwal, Divya
    Limdi, Jimmy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S528 - S528
  • [27] Mucosal Drug Concentration and Clinical Characteristics of Crohn's Disease Patients Receiving Anti-TNF Therapy
    Shinzaki, Shinichiro
    Iijima, Hideki
    Hiyama, Satoshi
    Inoue, Takahiro
    Fujii, Hironobu
    Yamaguchi, Toshio
    Araki, Manabu
    Kawai, Shoichiro
    Hayashi, Yoshito
    Watabe, Kenji
    Tsujii, Masahiko
    Takehara, Tetsuo
    GASTROENTEROLOGY, 2015, 148 (04) : S852 - S852
  • [28] Investigation of Crohn's disease patients receiving anti-TNF α therapy after surgery for intestinal stenosis
    Kuriyama, T.
    Iizuka, B.
    Kashiwagi, H.
    Hara, T.
    Ito, A.
    Omori, T.
    Yonezawa, M.
    Tokushige, K.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S296 - S296
  • [29] Proactive TDM for Crohn's Disease Patients in Clinical Remission Under Anti-TNF Treatment: Current State of Evidence
    Torres, Joana
    Bonovas, Stefanos
    Fiorino, Gionata
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (09): : 1338 - 1339
  • [30] Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn's disease
    Eder, Piotr
    Korybalska, Katarzyna
    Lykowska-Szuber, Liliana
    Krela-Kazmierczak, Iwona
    Stawczyk-Eder, Kamila
    Klimczak, Katarzyna
    Szymczak, Aleksandra
    Linke, Krzysztof
    Witowski, Janusz
    CYTOKINE, 2015, 76 (02) : 288 - 293